Incretin Mimetic Can Cause Severe, Disabling Joint Pain, FDA Warns

(August 31, 2015, 2:10 PM EDT) -- SILVER SPRING, Md. — Incretin mimetic diabetes drug Januvia, Onglyza and Tradjenta can cause severe and disabling joint pain, the Food and Drug Administration warned Aug. 28.

In a drug safety...
To view the full article, register now.